Target intelligence / Profile preview

Lung epithelium

Molecular classification
Other
01

Overview

The lung epithelium is a specialized layer of cells lining the respiratory tract, serving as the primary interface between the external environment and the internal pulmonary system (StatPearls, 2023). It functions as a critical physical and biological barrier, utilizing mucociliary clearance and the secretion of antimicrobial substances to defend against inhaled pathogens and toxins (Nature Reviews Immunology, 2019). In the alveolar region, the epithelium is specialized for efficient gas exchange and produces pulmonary surfactant to maintain surface tension and prevent lung collapse (American Journal of Physiology, 2020). Dysregulation of the lung epithelium is central to the pathogenesis of chronic respiratory diseases like COPD, asthma, and cystic fibrosis, where epithelial-to-mesenchymal transition and barrier dysfunction occur (Lancet Respiratory Medicine, 2018). While the lung epithelium itself is a tissue rather than a single molecular target, it is the site of numerous therapeutic interventions (Journal of Clinical Investigation, 2021). Drugs targeting the epithelium typically act on specific proteins within these cells, such as the CFTR channel or various inflammatory signaling receptors, to restore homeostasis or alleviate symptoms.

Other names
Pulmonary epitheliumRespiratory epitheliumAirway epitheliumAlveolar epithelium
02

Mechanism of action

Pharmacological agents interact with specific molecular components within the lung epithelium, such as ion channels (e.g., CFTR), G protein-coupled receptors (e.g., ADRB2), and nuclear receptors (e.g., glucocorticoid receptors), to modulate cellular function, secretion, and inflammatory responses.

03

Biological functions

Immune responseOther
04

Disease associations

CancerInflammationInfectionOther
05

Safety considerations

Epithelial-mesenchymal transition (EMT)Epithelial denudationCiliary dyskinesiaSquamous metaplasiaIncreased permeability to pathogens
06

Interacting drugs

Ivacaftor

5 more in the full profile.

07

Biomarkers

Club cell secretory protein (CC16)Surfactant protein D (SP-D)Carcinoembryonic antigen (CEA)Cytokeratin fragments (CYFRA 21-1)

Beyond the preview

Go deeper on Lung epithelium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lung epithelium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call